| UBS (LUX) GLOBAL QUALITY DIVIDEND EQUITY Q-ACC | RVI GLOBAL VALOR | 14,90% | 53,39% | 75,77% | 143,55% |
| BGF US MID-CAP VALUE D2 USD | RVI USA SMALL/MID CAP | 4,31% | 29,51% | 41,94% | 143,48% |
| GOLDMAN SACHS GLOBAL EQUITY PARTNERS ESG PORTFOLIO R H USD CAP | RVI GLOBAL | 0,43% | 22,99% | 31,53% | 143,45% |
| JPM EUROPE EQUITY C (ACC) USD | RVI EUROPA | 12,63% | 54,77% | 71,35% | 143,44% |
| POLAR CAPITAL HEALTHCARE OPPORTUNITIES I USD DIS | SALUD | 5,50% | 19,06% | 33,69% | 143,41% |
| JPM ASIA PACIFIC EQUITY D (ACC) EUR | RVI ASIA EX-JAPÓN | 28,34% | 51,26% | 23,84% | 143,40% |
| JANUS HENDERSON GLOBAL LIFE SCIENCES A2 USD | BIOTECNOLOGÍA | 6,14% | 22,78% | 31,25% | 143,39% |
| JPM EUROPE EQUITY C (ACC) EUR | RVI EUROPA | 12,25% | 53,20% | 70,90% | 143,37% |
| VONTOBEL FUND-CREDIT OPPORTUNITIES E USD CAP | RETORNO ABSOLUTO | 3,58% | 50,26% | 63,11% | 143,32% |
| BGF US MID-CAP VALUE D2 EUR | RVI USA SMALL/MID CAP | 3,95% | 28,20% | 41,55% | 143,26% |
